Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27e1ea5f65e8f958e48f1a9d53fdbb45 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2220-80 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-3804 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-291 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-101 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D15-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-291 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 |
filingDate |
2018-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af3518da24d0a90447927a9999443b20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a0bd8901488a754aa5f25bc74166fc3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dca9b61a4a4c5197911015525202db1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71e0c17117cc5bb490a953bd37aa4447 |
publicationDate |
2018-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018258416-A1 |
titleOfInvention |
Chemotherapeutic drug-conjugated resins and their preferential binding of methylated dna |
abstract |
Ligands and methods for selectively binding hypermethylated DNA from a sample. The ligands include a CG-region binding molecule-conjugated resin derived from the aminoglycoside antibiotic amikacin. Furthermore, the CG-region binding molecule may be conjugated to the resin with a crosslinker and/or may be modified with one or more of long chain and short chain alkyl, aryl, piperazinyl, piperidyl, and pyrrolidyl groups. Such ligands are used in methods for contacting a sample to thereby selectively bind hypermethylated DNA. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10232345-B2 |
priorityDate |
2017-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |